脑深部电刺激术在帕金森病治疗中的研究进展
Research Progress of Deep Brain Stimulation in the Treatment of Parkinson’s Disease
摘要: 帕金森病(Parkinson’s disease, PD)是一种与年龄相关的进行性神经退行性疾病,其发生发展与多巴胺能神经元线粒体功能障碍有关,帕金森病的治疗干预目前仅限于对症治疗,主要是多巴胺能药物和脑深部电刺激术(DBS)。DBS靶点的选择是复杂的,需根据患者的运动性症状、非运动性症状综合考虑,为PD患者在DBS选择合适的目标靶点提供依据。现有DBS靶点的疗效有限,目前所使用的DBS靶点不能解决PD患者的所有症状,临床医生应当根据患者的临床症状来选择合适的DBS靶点。本文论述了PD的发病机制,总结了当前针对PD的脑深部电刺激治疗不同靶点的疗效情况,为PD患者选择合适的目标靶点提供依据,在获得最佳治疗的同时,减少副作用,提高患者的生存质量。
Abstract: Parkinson’s Disease (PD) is an age-related progressive neurodegenerative disease, its occurrence and development are related to mitochondrial dysfunction of dopaminergic neurons. At present, the therapeutic intervention of Parkinson’s disease is limited to symptomatic treatment, mainly dopaminergic drugs and deep brain stimulation (DBS). The selection of the target of DBS is complicated, and it needs to be comprehensively considered according to the motor symptoms and non-motor symptoms of patients, so as to provide a basis for the selection of appropriate targets in DBS for patients with PD. The efficacy of existing DBS targets is limited, and the DBS targets currently used can not solve all the symptoms of patients with PD. Clinicians should choose the appropriate DBS targets according to the clinical symptoms of patients. This paper discusses the pathogenesis of PD, summarizes the current therapeutic effect of different targets of deep brain stimulation therapy for PD, and provides a basis for patients with PD to select suitable targets to reduce side effects while obtaining the best treatment and improve the quality of life of patients.
文章引用:赵德斌, 赵宁辉. 脑深部电刺激术在帕金森病治疗中的研究进展[J]. 临床医学进展, 2025, 15(3): 1595-1603. https://doi.org/10.12677/acm.2025.153781

参考文献

[1] Dorsey, E.R., Sherer, T., Okun, M.S. and Bloem, B.R. (2018) The Emerging Evidence of the Parkinson Pandemic. Journal of Parkinsons Disease, 8, S3-S8. [Google Scholar] [CrossRef] [PubMed]
[2] Coriolano, M.D.G.W.D.S., Balbino, J.M.D.S., SILVA, B.R.V.D., Cabral, E.D., Asano, A.G., Lins, O.G., et al. (2014) Pain Characterization in Patients with Parkinson’s Disease. Revista Dor, 15, 78-82. [Google Scholar] [CrossRef
[3] Malek, N. (2019) Deep Brain Stimulation in Parkinson’s Disease. Neurology India, 67, 968-978. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, H., Gao, H., Jiao, T. and Luo, Z. (2016) A Meta-Analysis of the Pedunculopontine Nucleus Deep-Brain Stimulation Effects on Parkinson’s Disease. NeuroReport, 27, 1336-1344. [Google Scholar] [CrossRef] [PubMed]
[5] Luquin, M., Kulisevsky, J., Martinez-Martin, P., Mir, P. and Tolosa, E.S. (2017) Consensus on the Definition of Advanced Parkinson’s Disease: A Neurologists-Based Delphi Study (CEPA Study). Parkinsons Disease, 2017, Article ID: 4047392. [Google Scholar] [CrossRef] [PubMed]
[6] Chou, K.L., Taylor, J.L. and Patil, P.G. (2013) The MDS-UPDRS Tracks Motor and Non-Motor Improvement Due to Subthalamic Nucleus Deep Brain Stimulation in Parkinson Disease. Parkinsonism & Related Disorders, 19, 966-969. [Google Scholar] [CrossRef] [PubMed]
[7] Peng, L., Fu, J., Ming, Y., Zeng, S., He, H. and Chen, L. (2018) The Long-Term Efficacy of STN vs GPI Deep Brain Stimulation for Parkinson Disease: A Meta-Analysis. Medicine, 97, e12153. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, J., Pan, R., Cui, Y., Wang, Z. and Li, Q. (2021) Effects of Deep Brain Stimulation in the Subthalamic Nucleus on Neurocognitive Function in Patients with Parkinson’s Disease Compared with Medical Therapy: A Meta-Analysis. Frontiers in Neurology, 12, Article 610840. [Google Scholar] [CrossRef] [PubMed]
[9] 艾祥柏, 黄小淦, 王诒田, 等. 帕金森病不同靶点脑深部电刺激术的疗效研究进展[J]. 海南医学院学报, 2023, 29(21): 1664-1670.
[10] Rango, M., Dossi, G., Squarcina, L. and Bonifati, C. (2020) Brain Mitochondrial Impairment in Early‐Onset Parkinson’s Disease with or without pink1 Mutation. Movement Disorders, 35, 504-507. [Google Scholar] [CrossRef] [PubMed]
[11] Neustadt, J. and Pieczenik, S.R. (2008) Medication‐Induced Mitochondrial Damage and Disease. Molecular Nutrition & Food Research, 52, 780-788. [Google Scholar] [CrossRef] [PubMed]
[12] Blagov, A., Postnov, A., Sukhorukov, V., Popov, M., Uzokov, J. and Orekhov, A. (2024) Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson’s Disease. Frontiers in Bioscience-Landmark, 29, Article 36. [Google Scholar] [CrossRef] [PubMed]
[13] Haque, M.E., Akther, M., Azam, S., Kim, I., Lin, Y., Lee, Y., et al. (2021) Targeting α‐Synuclein Aggregation and Its Role in Mitochondrial Dysfunction in Parkinson’s Disease. British Journal of Pharmacology, 179, 23-45. [Google Scholar] [CrossRef] [PubMed]
[14] Mantri, S., Morley, J.F. and Siderowf, A.D. (2019) The Importance of Preclinical Diagnostics in Parkinson Disease. Parkinsonism & Related Disorders, 64, 20-28. [Google Scholar] [CrossRef] [PubMed]
[15] Váradi, C. (2020) Clinical Features of Parkinson’s Disease: The Evolution of Critical Symptoms. Biology, 9, Article 103. [Google Scholar] [CrossRef] [PubMed]
[16] Matuja, W.B. and Aris, E.A. (2008) Motor and Non-Motor Features of Parkinson’s Disease. East African Medical Journal, 85, 3-9. [Google Scholar] [CrossRef] [PubMed]
[17] Jankovic, J., Schwartz, K.S. and Ondo, W. (1999) Re-Emergent Tremor of Parkinson’s Disease. Journal of Neurology, Neurosurgery & Psychiatry, 67, 646-650. [Google Scholar] [CrossRef] [PubMed]
[18] Baradaran, N., Tan, S.N., Liu, A., Ashoori, A., Palmer, S.J., Wang, Z.J., et al. (2013) Parkinson’s Disease Rigidity: Relation to Brain Connectivity and Motor Performance. Frontiers in Neurology, 4, Article 67. [Google Scholar] [CrossRef] [PubMed]
[19] Huang, C., Chu, H., Zhang, Y. and Wang, X. (2018) Deep Brain Stimulation to Alleviate Freezing of Gait and Cognitive Dysfunction in Parkinson’s Disease: Update on Current Research and Future Perspectives. Frontiers in Neuroscience, 12, Article 29. [Google Scholar] [CrossRef] [PubMed]
[20] Ward, M. and Mammis, A. (2017) Deep Brain Stimulation for the Treatment of Dejerine-Roussy Syndrome. Stereotactic and Functional Neurosurgery, 95, 298-306. [Google Scholar] [CrossRef] [PubMed]
[21] Sauerbier, A., Rosa-Grilo, M., Qamar, M.A. and Chaudhuri, K.R. (2017) Nonmotor Subtyping in Parkinson’s Disease. International Review of Neurobiology, 133, 447-478. [Google Scholar] [CrossRef] [PubMed]
[22] Giugni, J.C. and Okun, M.S. (2014) Treatment of Advanced Parkinson’s Disease. Current Opinion in Neurology, 27, 450-460. [Google Scholar] [CrossRef] [PubMed]
[23] Martinez-Martin, P., Falup Pecurariu, C., Odin, P., Hilten, J.J., Antonini, A., Rojo-Abuin, J.M., et al. (2012) Gender-Related Differences in the Burden of Non-Motor Symptoms in Parkinson’s Disease. Journal of Neurology, 259, 1639-1647. [Google Scholar] [CrossRef] [PubMed]
[24] Hughes, K.C., Gao, X., Baker, J.M., Stephen, C.D., Kim, I.Y., Valeri, L., et al. (2021) Non-motor Features of Parkinson’s Disease in Women. Journal of Parkinson’s Disease, 11, 1237-1246. [Google Scholar] [CrossRef] [PubMed]
[25] Pycroft, L., Stein, J. and Aziz, T. (2018) Deep Brain Stimulation: An Overview of History, Methods, and Future Developments. Brain and Neuroscience Advances, 2, 1-6. [Google Scholar] [CrossRef] [PubMed]
[26] Eser, P., Kocabicak, E., Bekar, A. and Temel, Y. (2024) Insights into Neuroinflammatory Mechanisms of Deep Brain Stimulation in Parkinson’s Disease. Experimental Neurology, 374, Article ID: 114684. [Google Scholar] [CrossRef] [PubMed]
[27] Mirza, S., Yazdani, U., Dewey III, R., Patel, N., Dewey, R.B., Miocinovic, S., et al. (2017) Comparison of Globus Pallidus Interna and Subthalamic Nucleus in Deep Brain Stimulation for Parkinson Disease: An Institutional Experience and Review. Parkinsons Disease, 2017, Article ID: 3410820. [Google Scholar] [CrossRef] [PubMed]
[28] Mansouri, A., Taslimi, S., Badhiwala, J.H., Witiw, C.D., Nassiri, F., Odekerken, V.J.J., et al. (2018) Deep Brain Stimulation for Parkinson’s Disease: Meta-Analysis of Results of Randomized Trials at Varying Lengths of Follow-Up. Journal of Neurosurgery, 128, 1199-1213. [Google Scholar] [CrossRef] [PubMed]
[29] Wal, A., Wal, P., Vig, H., Jain, N.K., Rathore, S., Krishnan, K., et al. (2023) Treatment of Parkinson’s Disease: Current Treatments and Recent Therapeutic Developments. Current Drug Discovery Technologies, 20, e120523216834. [Google Scholar] [CrossRef] [PubMed]
[30] Negida, A., Elminawy, M., El Ashal, G., Essam, A., Eysa, A. and Abd Elalem Aziz, M. (2018) Subthalamic and Pallidal Deep Brain Stimulation for Parkinson’s Disease. Cureus, 10, e2232. [Google Scholar] [CrossRef] [PubMed]
[31] Shapiro, M.B., Vaillancourt, D.E., Sturman, M.M., Verhagen Metman, L., Bakay, R.A.E. and Corcos, D.M. (2007) Effects of STN DBS on Rigidity in Parkinson’s Disease. IEEE Transactions on Neural Systems and Rehabilitation Engineering, 15, 173-181. [Google Scholar] [CrossRef] [PubMed]
[32] Bardon, J., Kurcova, S., Chudackova, M., Otruba, P., Krahulik, D., Nevrly, M., et al. (2022) Deep Brain Stimulation Electrode Position Impact on Parkinsonian Non-Motor Symptoms. Biomedical Papers, 166, 57-62. [Google Scholar] [CrossRef] [PubMed]
[33] Sun, L., Xu, F., Ma, W., Huang, Y. and Qiu, Z. (2016) Deep Brain Stimulation of Pallidal versus Subthalamic for Patients with Parkinson’s Disease: A Meta-Analysis of Controlled Clinical Trials. Neuropsychiatric Disease and Treatment, 12, 1435-1444. [Google Scholar] [CrossRef] [PubMed]
[34] David, F.J., Munoz, M.J. and Corcos, D.M. (2020) The Effect of STN DBS on Modulating Brain Oscillations: Consequences for Motor and Cognitive Behavior. Experimental Brain Research, 238, 1659-1676. [Google Scholar] [CrossRef] [PubMed]
[35] Breit, S., Schulz, J.B. and Benabid, A. (2004) Deep Brain Stimulation. Cell and Tissue Research, 318, 275-288. [Google Scholar] [CrossRef] [PubMed]
[36] Williams, N.R., Foote, K.D. and Okun, M.S. (2024) Subthalamic Nucleus versus Globus Pallidus Internus Deep Brain Stimulation: Translating the Rematch into Clinical Practice. NPJ Parkinsons Disease, 1, 24-35.
[37] Dayal, V., Grover, T., Limousin, P., Akram, H., Cappon, D., Candelario, J., et al. (2018) The Effect of Short Pulse Width Settings on the Therapeutic Window in Subthalamic Nucleus Deep Brain Stimulation for Parkinson’s Disease. Journal of Parkinsons Disease, 8, 273-279. [Google Scholar] [CrossRef] [PubMed]
[38] Ramirez-Zamora, A. and Ostrem, J.L. (2018) Globus Pallidus Interna or Subthalamic Nucleus Deep Brain Stimulation for Parkinson Disease. JAMA Neurology, 75, 367-372. [Google Scholar] [CrossRef] [PubMed]
[39] Ni, Z., Kim, S.J., Phielipp, N., Ghosh, S., Udupa, K., Gunraj, C.A., et al. (2018) Pallidal Deep Brain Stimulation Modulates Cortical Excitability and Plasticity. Annals of Neurology, 83, 352-362. [Google Scholar] [CrossRef] [PubMed]
[40] Kubben, P., Degeneffe, A., Kuijf, M., Ackermans, L. and Temel, Y. (2018) Comparing Deep Brain Stimulation in the Ventral Intermediate Nucleus versus the Posterior Subthalamic Area in Essential Tremor Patients. Surgical Neurology International, 9, Article 244. [Google Scholar] [CrossRef] [PubMed]
[41] Wong, J.K., Viswanathan, V.T., Nozile-Firth, K.S., Eisinger, R.S., Leone, E.L., Desai, A.M., et al. (2020) STN versus GPI Deep Brain Stimulation for Action and Rest Tremor in Parkinson’s Disease. Frontiers in Human Neuroscience, 14, Article 578615. [Google Scholar] [CrossRef] [PubMed]
[42] Lozano, A.M. (2000) Vim Thalamic Stimulation for Tremor. Archives of Medical Research, 31, 266-269. [Google Scholar] [CrossRef] [PubMed]
[43] Timmermann, L. and Volkmann, J. (2010) Tiefe Hirnstimulation zur Behandlung von Dystonie und Tremor. Der Nervenarzt, 81, 680-687. [Google Scholar] [CrossRef] [PubMed]
[44] Liu, H., Zhang, K., Yang, A. and Zhang, J. (2015) Deep Brain Stimulation of the Subthalamic and Pedunculopontine Nucleus in a Patient with Parkinson’s Disease. Journal of Korean Neurosurgical Society, 57, 303-306. [Google Scholar] [CrossRef] [PubMed]
[45] Ramirez-Zamora, A., Smith, H., Kumar, V., Prusik, J., Phookan, S. and Pilitsis, J.G. (2016) Evolving Concepts in Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Tremor: Surgical Neuroanatomy and Practical Considerations. Stereotactic and Functional Neurosurgery, 94, 283-297. [Google Scholar] [CrossRef] [PubMed]
[46] Baumgartner, A.J., Thompson, J.A., Kern, D.S. and Ojemann, S.G. (2022) Novel Targets in Deep Brain Stimulation for Movement Disorders. Neurosurgical Review, 45, 2593-2613. [Google Scholar] [CrossRef] [PubMed]
[47] Thevathasan, W. and Moro, E. (2019) What Is the Therapeutic Mechanism of Pedunculopontine Nucleus Stimulation in Parkinson’s Disease? Neurobiology of Disease, 128, 67-74. [Google Scholar] [CrossRef] [PubMed]